Financial Presentation Materials for Q1 FY2026 Ending September 2026

Overview of Performance

The consolidated results for Q1 FY2026 ending September showed net sales of 33,842 million yen (YoY -0.4%) and operating income of 1,887 million yen (YoY -2.3%). Although operating income decreased due to an increase in selling, general and administrative expenses, net income increased by 37.9% year-over-year due to gains on sales of investment securities. The progress rates against the full-year plan were healthy at 26.0% for net sales, 30.4% for operating income, and 49.8% for net income.

Segment Performance and Outlook

By segment, Fine Chemicals recorded net sales of 11,067 million yen (YoY -1.8%) and operating income of 733 million yen (YoY +2.6%), showing a decline in sales but increase in profits. Industrial Products delivered net sales of 9,699 million yen (YoY +0.6%) and operating income of 866 million yen (YoY +3.3%), with both sales and profits increasing. Sustainability posted net sales of 2,704 million yen (YoY +11.5%) and operating income of 258 million yen (YoY -12.8%), with sales up but profits down. Life Sciences saw net sales of 10,011 million yen (YoY -3.3%) and operating income of 484 million yen (YoY -22.9%), declining in both sales and profits. Considering the factors behind these changes, we will focus on achieving the full-year plan.